This suggested that TRIM14 maintained Dvl2 stability to activate the Wnt/β-catenin signaling pathway, thereby promoting OXA resistance and autophagy in cancer cells, highlighting its potential as a target to overcome drug resistance. This evidence concerns the gene TRIM14 and cancer.